viernes, 29 de marzo de 2019

Stroke Shoe Retrains the Brain - Ivanhoe Broadcast News, Inc.

Stroke Shoe Retrains the Brain - Ivanhoe Broadcast News, Inc.



Marketing


DENVER, Colo. (Ivanhoe Newswire) — Most people with diabetes have type two diabetes, with an assortment of drugs at their disposal. But somewhere between one-point-five and three million Americans are living with type one diabetes and their only drug option, insulin, is what keeps them alive.




TAMPA, Fla. (Ivanhoe Newswire) — In the United States every year close to 800,000 people suffer a stroke: a sudden interruption in the blood supply of the brain. Many are left with a dragging foot. But doctors are working on an inexpensive way to fix their footing.




ATLANTA, Ga. (Ivanhoe Newswire) — More than 200,000 children are living with type one diabetes in the U.S. Meet three young women who have managed the disease since childhood and are now dedicating their lives to helping families dealing with diabetes.




HOUSTON, Texas (Ivanhoe Newswire) — OCD, obsessive compulsive disorder, only affects about two percent of the population, but symptoms are usually severe. Clinical trials are targeting new receptors in the brain and that might mean positive news on the medical horizon.




FORT LAUDERDALE, Fla. (Ivanhoe Newswire) — More than 5.7 million Americans suffer from chronic wounds that won’t heal. Now a new, easy to use treatment some are calling a “magic powder” is helping patients heal much faster!







Doctor's In-depth Interview of the week
 
Fighting Pacemaker Infections
Valay Parikh, MD, FACC, FHRS, Cardiac Electrophysiologist
Baptist Health System, San Antonio

 




Quote of the week:

The fundamental cause of the trouble in the modern world today is that the stupid are cocksure while the intelligent are full of doubt.” 

— Bertrand Russell



 





If you know of an innovative medical treatment, send us the name of the treatment,  name of the doctor and city. We may be able to cover it in one of our series: newsalert@ivanhoe.com

Website Informationwebdoctor@ivanhoe.com

Content Licensing: jcherry@ivanhoe.com

No hay comentarios:

Publicar un comentario